According to Old Farmer's Almanac, Ember Days are a folklore tradition. Three days shortly after a holiday can preview the next 3 months' weather in MS.

In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Viking Therapeutics (VKTX – Research Report). The company’s shares closed today at $26.61.

A girl has died, and multiple people were detained after a shooting in south Phoenix. Phoenix police said officers received a call about "unknown trouble" near Sixth and Wier Avenues just before 9:15 ...

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $26.61, representing a +1.88% change from its previous close.

Discover why Altimmune (ALT) and Viking Therapeutics (VKTX) are top picks for high-risk investors. Click here to read my most ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

The dynamics of the Krabbe disease market are expected to shift in the coming years due to the emergence of a new pipeline, increasing awareness of t ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

With VKTX surging on clinical results and NVO investing to cement market share, investors face a high-stake GLP-1 showdown.

Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two ...

Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.